Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

142.81
BATS BZX Real-Time Price
As of 11:37am ET
 -0.19 / -0.13%
Today’s Change
130.09
Today|||52-Week Range
181.81
-12.02%
Year-to-Date
AMGN Regular Dividend: AMGN will begin trading ex-dividend on 02/11/16 with a $1.00 dividend payable to shareholders of record as of 02/16/16.

Today’s Trading

Previous close143.00
Today’s open141.02
Day’s range140.82 - 145.63
Volume1,455,896
Average volume (3 months)3,857,300
Market cap$107.9B
Dividend yield2.79%
Data as of 11:37am ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+0.90%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+7.30%
P/E ratio17.2
Price/Sales6.12
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.75+0.88%
BIIBBiogen-0.81-0.32%
BXLTBaxalta Inc+0.08+0.22%
BAXBaxter International...+0.40+1.11%
Data as of 11:38am ET, 02/09/2016

Financials

Next reporting dateApril 19, 2016
EPS forecast (this quarter)$2.59
Annual revenue (last year)$20.0B
Annual profit (last year)$5.2B
Net profit margin25.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts

Partner Offers